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Abstract
Background
Existing reading schemes for chest X-ray (CXR) used to grade the extent of disease sever-
ity at diagnosis in patients with pulmonary tuberculosis (PTB) are often based on numerical
scores that summate specific radiographic features. However, since PTB is known to exhibit
a wide heterogeneity in pathology, certain features might be differentially associated with
clinical parameters of disease severity.
Objective
We aimed to grade disease severity in PTB patients at diagnosis and after completion of
DOTS treatment by developing a reading scheme based on five different radiographic mani-
festations and analyze their association with the clinical parameters of systemic involve-
ment and infectivity.
Methods
141 HIV-negative adults with newly diagnosed sputum smear-positive PTB were enrolled in
a prospective observational study in Hyderabad, India. The presence and extent on CXRs
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of five radiographic manifestations, i.e., lung involvement, alveolar infiltration, cavitation,
lymphadenopathy and pleural effusion, were classified using the new reading scheme by
using a four-quadrant approach. We evaluated the inter-reader reliability of each manifesta-
tion, and its association with BMI and sputum smear positivity at diagnosis. The presence
and extent of these radiographic manifestations were further compared with CXRs on com-
pletion of DOTS treatment.
Results
At diagnosis, an average lung area of 51.7% +/- 23.3% was affected by radiographic abnor-
malities. 94% of the patients had alveolar infiltrates, with 89.4% located in the upper quad-
rants, suggesting post primary PTB and in 34.8% of patients cavities were found. We
further showed that the extent of affected lung area was a negative predictor of BMI (β value
-0.035, p 0.019). No significant association of BMI with any of the other CXR features was
found. The extent of alveolar infiltrates, along with the presence of cavitation, were strongly
associated with sputum smear positivity. The microbiological cure rate in our cohort after 6
months of DOTS treatment was 95%. The extent of the affected lung area in these patients
decreased from 56.0% +/- 21.5% to 31.0 +/- 20% and a decrease was also observed in the
extent of alveolar infiltrates from 98.4% to 25.8% in at least one quadrant, presence of cavi-
ties from 34.8% to 1.6%, lymphadenopathy from 46.8% to 16.1%, and pleural effusion from
19.4% to 6.5%.
Conclusions
We established a new assessment scheme for grading disease severity in PTB by specifi-
cally considering five radiographic manifestations which were differently associated with the
BMI and sputum smear positivity, changed to a different extent after 6 months of treatment
and exhibited an excellent agreement between radiologists. Our results suggest that this
reading scheme might contribute to the estimation of disease severity with respect to differ-
ences in disease pathology. Further studies are needed to determine a correlation with
short and long-term pulmonary function impairment and whether there would be any benefit
in lengthening or modulating therapy based on this CXR severity assessment.
Introduction
Tuberculosis (TB) remains a global public health problem with an estimated 9.0 million inci-
dent cases and 1.5 million deaths in 2013 [1]. India alone accounts for an estimated 2.2 million
cases [2]. According to the WHO guidelines for TB control, early diagnosis of pulmonary TB
(PTB) by smear microscopy remains the main procedure in low-income settings, even though
it has the drawbacks of low specificity and variable sensitivity [3]. In India, the Revised
National Tuberculosis Control Program RNTCP recommends the use of chest radiography
(CXR), where available, as an additional screening tool to increase the sensitivity of the diag-
nostic algorithm [4]. In this context, certain radiographic features and scoring systems have
been described for the identification of PTB by CXR [5]. However, these features are not fully
pathognomonic for PTB and lack reproducibility, especially when used in the field [5–8].
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CXR also potentially provides useful information for grading the extent of pulmonary
involvement and disease severity at diagnosis, as well as for assessing treatment outcome [9,
10]. The pathologic features of PTB exhibit wide heterogeneity [10]. In this context, e.g., in
reports from the pre-antibiotic era, at least two distinct types of pathology in pulmonary TB—a
nodular form and tuberculous pneumonia—have been described [11]. Therefore, it seems
likely that specific radiographic features at diagnosis, as well as after treatment, might differ
between patients not only as a result of disease severity, but also differences in disease pathol-
ogy [10, 11]. The extent of infected lung tissue destruction is linked to disease severity, bacillary
load, and disease spread [11]. In addition, lung remodeling and pathological scarring often
occurs during the course of the disease, despite pathogen clearance under Directly Observed
Treatment Short-course (DOTS) treatment [12–16]. As a result, short- and long-term disease
effects can lead to persistent impairment of lung function, despite microbiological cure, in a
significant proportion of patients [13, 17]. To analyze whether specific radiographic features
are related to disease severity at diagnosis, they can be correlated with other well-known
parameters of disease severity and infectivity, such as BMI, sputum smear positivity and the
FEV1. Some of the CXR features have already been found to be related to the extent of pulmo-
nary pathology and are associated with clinical signs of disease severity and infectivity: BMI is a
well-recognized clinical measure of TB severity [18–20]; and malnutrition is also known to be
associated with the radiographic extent of pulmonary disease [14, 20–22]. Several studies have
also shown that patients with cavitary PTB have higher bacterial loads in their sputum [23–26].
Moreover, in one study, the area of alveolar infiltrates was also found to be associated with spu-
tum smear positivity [18].
However, these studies used different CXR reading schemes for the characterization of pul-
monary involvement, e.g., by dividing the lungs into parts: upper and lower lobes [23, 26],
thirds [13, 18], quarters [27], by using additional scores [13, 27] or by grading the density of
infiltrates [20, 27]. Consequently, a new numerical scoring system was suggested to grade dis-
ease severity at diagnosis and predict treatment outcome by using two-month smear status as
an outcome measure [22]. This score was derived from the percentage of affected lung by grad-
ing visual estimation of the extent of any dense or patchy opacification, cavitation, or other
pathology as percentage plus 40, if cavitation was present [22]. These authors also demon-
strated that this numerical score correlated with BMI, sputum smear positivity, as well as
FEV1, as well-known clinical parameters of disease severity [22]. However, the expression of
pulmonary involvement as a numerical score might not reflect the heterogeneity of pulmonary
pathology since different CXR features are not related to disease severity to the same extent.
For instance, areas of higher density on CXR due to pulmonary scaring which also contribute
to the extent of the area of lung affected might not mirror active disease and thus the extent of
tissue destruction to the same degree than alveolar infiltrates which are most likely reflecting
the early inflammatory state of acute post primary PTB and in particular of tuberculous pneu-
monia [11].
We hypothesized that distinct CXR features are differentially associated with disease sever-
ity and might thus be differently associated to the BMI and sputum smear positivity as clinical
parameters of disease severity. In addition it is not known whether and to what extent specific
CXR features at diagnosis are associated with lung impairment after the completion of treat-
ment. Therefore to independently grade different CXR features that have been associated with
PTB might allow an improved description of CXR changes in TB patients after DOTS treat-
ment in the field, which might help to facilitate more tailor-made treatment in TB care, in gen-
eral [24, 28]. The aim of this study was to grade disease severity in HIV-negative adult patients
with newly diagnosed sputum smear-positive PTB, in a prospective study in Hyderabad/India,
using a new system that independently determines the presence and extent of five different
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manifestations of radiographic findings that are associated with PTB [18, 24, 28, 29]. The fol-
lowing radiographic manifestations were classified: (i) extent of lung involvement, (ii) extent of
alveolar infiltration, (iii) the presence of cavitation, (iv) the presence of lymphadenopathy, and
(v) the presence of pleural effusion. With regard to the manifestation `extent of lung involve-
ment´, we combined and simplified the reading schemes for this manifestation suggested by
Ralph et al. [22], and the radiographic reading scheme suggested by Baez-Saldana et al. [27]
making use of a quadrant scheme. In addition, the presence or absence of cavities, mediastinal
and/or hilar lymphadenopathy and pleural effusion was noted, but the extent of these manifes-
tations was not assessed. In order to justify the assumption that each manifestation of our CXR
reading scheme correlates with other well-known parameters of disease severity at diagnosis,
we analyzed its association with the clinical parameters of systemic involvement (BMI) and
infectivity (sputum smear positivity). The presence and extent of the radiographic manifesta-
tions on CXR at diagnosis were further compared with those following the completion of 6
months of DOTS treatment, to further assess whether changes in the appearance of the differ-
ent CXR manifestations with treatment were associated with subsequent improvement.
Materials and Methods
Study design, setting, and participants
We performed an observational study at the Mahavir hospital and research center in Hyderabad,
India. The recruitment of study participants was carried out prospectively from July 26, 2011 to
November 21, 2013; all 141 individuals with PTB within the study period were recruited accord-
ing to the following inclusion criteria. We recruited only patients who were newly diagnosed
with a sputum smear-positive PTB disease, who did not have previous exposure to TB antibiotic
therapy and were registered in the Hyderabad DOTS program at Mahavir hospital. All partici-
pants tested negative for HIV. The diagnostic criterion for the presence of PTB was the presence
of at least two initial sputum smear examinations positive for Acid-Fast Bacillus (AFB), in accor-
dance with the Indian technical and operational guidelines for TB control [30]. The DOTS treat-
ment was according to the RNTCP and consisted of one intensive phase with isoniazid (H),
rifampicin (R), pyrazinamide (Z), and ethambutol (E) administered under direct observation
three times per week on alternate days, for 2 months, followed by a continuation phase for 4
months with H and R administered thrice per week on alternate days with at least the first dose
of every week being directly observed [31, 32]. The dosage strengths of drugs used under DOTS
consist of H: (600 mg), R: (450 mg), Z: (1500 mg), E: (1200 mg) or S (streptomycin): (750 mg).
Patients who weighed 60 kg or more received additional 150 mg R, patients who were more
than 50 years old received 500 mg S instead of E, patients who weighed less than 30 kg received
drugs according to body weight [31]. All study participants gave their written informed consent
before the investigations and the study was approved by the institutional ethics committee for
bio-medical research, BhagwanMahavir Medical Research Centre, Hyderabad, India.
Variables, data sources and measurements
Demographic data, including gender, age and BMI, along with data on smoking and drinking
habits, were recorded using the hospital’s standard DOTS program questionnaire. The final
treatment outcome was recorded as cured, failed, default, lost to follow-up, and death. The
demographic data were obtained directly from patients or their relatives during an interview
performed by a trained researcher at initial recruitment to the study. Other relevant clinical
data, including the results of the sputum smear microscopy and the serological HIV test result,
were obtained from the hospital’s TB control program records and medical staff. Sputum
smears were examined at the time of diagnosis and after two month of treatment for AFB
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using Ziehl–Neelsen staining and graded by standard criteria as follows: no AFB in 100 High-
Power Field (HPF) (negative), 1–9 AFB in 100 HPF (Scanty), 10–99 AFB in 100 HPF (1+),
1–10 AFB per field in at least 50 HPF (2+) and> 10 AFB per HPF in at least 20 (3+) [33].
Assessment of the chest radiographs
All patients underwent postero-anterior CXR at the start of DOTS treatment using a Siemens
Heliophos D X-ray generator (Siemens, Mumbai-India). Because CXR is not part of the stan-
dard follow-up for PTB patients at Mahavir hospital’s DOTS program, only 62 patients also
underwent additional CXR after completing 6 months of treatment. CXRs were first assessed
by two radiologists who, by consensus, developed an assessment scheme for the radiographic
manifestations indicative of the presence and extent of lung involvement in PTB, as described
below. Subsequently, two independent radiologists analyzed these manifestations to assess
inter-reader reliability. All radiologists were blind in relation to the clinical data. In order to
define the extent of the two pulmonary manifestations area of lung involvement and alveolar
infiltrates, each lung was divided into two halves, an upper and a lower half, by a horizontal
line drawn at the level of the upper endplate of a thoracic vertebra situated immediately below
the tracheal carina. The four resulting quadrants were designated as follows: I, right upper
quadrant (RUQ), II, right lower quadrant (RLQ), III, left upper quadrant (LUQ), and IV, left
lower quadrant (LLQ) S1 Fig, and as proposed by Baez-Saldana et al. [27]. The total area of
lung affected by any parenchymal lesion was determined by counting the number of quadrants
involved, i.e., from one to four and each quadrant accounting for 25% of the total extent. This
is a more simplified scheme than the one recently proposed which is based on the total percent-
age of affected lung by visual estimation of the extent and density of opacification, cavitation,
or other pathology as a percentage of visible lung [22]. In a next step, the extent of alveolar
infiltrates was separately graded using the four-quadrant scheme. Alveolar infiltrate, a term
still preferably used by clinicians, relates to areas of patchy or confluent opacities, in contrast to
nodular lesions, airway disease, a miliary pattern, or parenchymal scarring. Moreover, cavities,
when present, were assigned to one or more quadrants, e.g., I for cavitation in RUQ. No
attempt was made to evaluate the size of the cavities, and the presence or absence of mediasti-
nal and/or hilar lymphadenopathy along with pleural effusion was noted, but the extent or
localization in the four-quadrant scheme of these manifestations was not assessed.
Statistical methods
Continuous variables were expressed as mean ± Standard Deviation (SD) or median ± Inter-
quartile Range (IQR) and categorical variables as the frequency count and percentage. Inter-
observer agreement between radiologists regarding categorical variables was assessed with
kappa statistics, the initial kappa values were prevalence and bias, adjusted as previously
described [34], and interpreted according to the approach of Landis et al. [35]. The agreement
in continuous variables was assessed using correlation analysis and the method of Bland and
Altman [36]. The association of individual CXR features and clinical characteristics was assessed
with univariable and multivariable regression analysis: linear regression was used for continuous
dependent variables, such as the BMI, and ordinal regression for ordinal dependent variables
such as the sputum smear microscopy. The goodness of fit of the regression models was evalu-
ated with ANOVA and goodness of fit tests for linear and ordinal regressions respectively, and
the amount of variation explained by the model with the R2 and pseudo R2 tests for linear and
ordinal regressions, respectively. In the case of ordinal regression, the proportional odds
assumption was assessed with the test of parallel lines. The differences between the extent of
CXR features at diagnosis and after completion of 6 months of DOTS treatment were analysed
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with theWilcoxon Signed Rank test, McNemar test, and repeated measures multinomial regres-
sion for continuous, categorical binary and categorical ordinal variables, respectively. The differ-
ence in BMI gain, depending on the affected lung area, was assessed with the Kruskal-Wallis
test. SPSS 21 (SPSS Inc., Chicago, Illinois-USA) was used for data analysis and values of p<0.05
were considered significant. The Strengthening the Reporting of Observational Studies in Epide-
miology (STROBE) Guidelines were used as a reporting guide for this observational study [37].
Results
Socio-demographic and clinical characteristics of study participants
We carried out a survey in 141 newly diagnosed PTB patients whose main socio-demographic
and clinical characteristics are shown in Table 1. This was a relatively young population
26.9 ± 11.4 years with an almost equal number of male 50.4% and female 49.6% participants.
AFB sputum smear microscopy showed that 58.1% of the patients had a bacterial burden of 2
+ or 3+, 33.3% had 1+ and 8.5% had a scanty burden. Most of the patients 93.6% had negative
sputum results after two months of DOTS treatment Table 1. The result for the final treatment
outcome in the 141 recruited patients was that 138 patients completed the 6 months treatment:
one patient defaulted and did not come back to the hospital, one patient died prematurely
shortly after starting therapy and another was transferred to another hospital. Two out of 138
patients who completed treatment were diagnosed with MDR and two patients who had been
previously reported as cured returned to the hospital following relapse.
Chest radiography (CXR) findings
The CXR for each patient after being enrolled in the study was evaluated. On average, 54.7% ±
23.3% of lung area was affected Table 2. The CXR revealed that 94.3% of patients had alveolar
Table 1. Characteristics of study participants.
Variable n = 141
Age mean (SD), (years) 26.9 ± 11.4
Gender n (%), male/female 71 (50.4)/70 (49.6)
BMI mean (SD), (Kg/m2) 16.3 ± 2.5
Smoking mean (SD), pack-year 0.20 ± 0.81
Drinking n (%), (yes/no) 27 (19.1)/114 (80.9)
Sputum smear grade at diagnosis n (%)
Scanty 12 (8.5)
1+ 47 (33.3)
2+ 35 (24.8)
3+ 47 (33.3)
2 months sputum smear status n (%)
Negative 132 (93.6)
Positive 9 (6.4)
6 months outcome n (%)
Cured 134 (95)
Failed 4 (2.8)
Default 1 (0.7)
Transferred 1 (0.7)
Died 1 (0.7)
(SD) standard deviation.
doi:10.1371/journal.pone.0138070.t001
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infiltrates, with different levels ranging from the first to the fourth lung quadrant; in addition,
41.8% of patients had lymphadenopathy. Cavitation was present in 29.1% of patients. In a next
step, we assessed the presence of primary and post-primary PTB by dividing the patients into
two groups, according to the presence of alveolar infiltrates in the upper or lower quadrants of
their CXRs, and found that 10.6% had lower-lobe infiltrate and 89.4% had upper-lobe infiltrate
Table 3, which suggests that most of the patients in our cohort were most likely affected by
post-primary PTB, according to conventional criteria [28].
Assessment of the inter-reader reliability of the CXR features according
to our assessment scheme
The results of the inter-reader reliability evaluation for the identification of the CXRs manifes-
tations, i.e., (i) affected lung area, (ii) alveolar infiltrates, as well as the presence of (iii) cavita-
tion, (iv) pleural effusion, and (v) lymphadenopathy are summarized in Table 4. Our results
show a significant agreement among the radiologists in identifying the extent of alveolar infil-
trates. In addition, there was a high level of agreement 73% in identifying the affected lung
area. Pleural effusions were also identified with a high level of agreement. However, only a
moderate level of agreement was found when determining the presence of cavitation and only
a fair level of agreement when identifying the presence of lymphadenopathy. All kappa values
were prevalence-adjusted and bias-adjusted, a procedure that improved the level of agreement.
Table 2. Specific Chest Radiograph (CXR) features of lung involvement.
Variable n = 141
Alveolar inﬁltrates n (%)
None 8 (5.7)
1 quadrant 41 (29.1)
2 quadrants 61 (43.3)
3 quadrants 21 (14.9)
4 quadrants 10 (7.1)
Lymphadenopathy n (%), (yes/No) 59 (41.8)/82 (58.2)
Cavitation n (%)
None 100 (70.9)
1 Cavity 34 (24.1)
2 Cavities 7 (5)
Affected lung area mean (SD) 54.7 ± 23.3
Pleural effusion n (%), (yes/No) 23 (16.3)/118 (83.7)
(SD) standard deviation.
doi:10.1371/journal.pone.0138070.t002
Table 3. Chest Radiograph (CXR) results according to the presence of alveolar infiltrates in the upper
or lower lung lobe.
Variable n = 141 Lower lobe inﬁltrate Upper lobe inﬁltrate
Alveolar inﬁltrates n (%) 15 (10.6) 126 (89.4)
None 8 (5.7) 7 (46.7) 1 (0.8)
1 quadrant 41 (29.1) 7 (46.7) 34 (27)
2 quadrants 61 (43.3) 1 (6.7) 60 (47.6)
3 quadrants 21 (14.9) 21 (16.7)
4 quadrants 10 (7.1) 10 (7.9)
doi:10.1371/journal.pone.0138070.t003
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As an example, S2A, S2B, S2C and S2D Fig show CXRs with respective agreement or disagree-
ment among radiologists in interpreting these lesions as cavities.
The affected lung area is negatively associated with the BMI
Consequently, in order to assess whether individual CXR manifestations could be used as cor-
relates of disease severity, we analyzed their association with BMI, as an indicator of disease
severity, and the degree of sputum smear positivity as an indicator of infectivity [20, 24]. Ini-
tially, we employed BMI as dependent variable to test which CXR feature could be a predictor
of this parameter with linear regression analysis. The initial univariable analysis revealed that
the extent of alveolar infiltrates and the affected lung area are negative predictors of BMI (β
value -0.620, p 0.008) and (β value -0.034, p<0.0001), (Table 5, models 1 and 2, respectively);
however, when the two variables were analyzed together in a multivariable model, only the
extent of affected lung area became a negative predictor of BMI (β value -0.035, p 0.019),
(Table 5, model 3). No significant association of BMI with any of the other CXR features was
found.
The extent of alveolar infiltrates and the presence of cavitation are
associated with the degree of sputum smear positivity
As a next step, we assessed the association of the presence and extent of all CXR manifestations
with the degree of sputum smear positivity at baseline. We first evaluated the association of
each CXR manifestation by univariable analysis, followed by multivariable analysis, which
included only those CXR manifestations with significant associations in univariable analysis.
For this purpose, we used sputum smear positivity as an ordinal categorical variable, for which
there is a clear order within the different categories of the variable. Accordingly, in addition to
being able to classify a TB patient as sputum smear- positive or negative, the patient could be
assigned to one of the four smear categories: scanty, 1+, 2+ and 3+; e.g., a patient in a higher
Table 4. Inter-rater agreement on Chest Radiograph (CXR) findings.
Inter-rater agreement for categorical
variables
Kappa P value Prevalence and bias adjusted
kappa
Interpretation of prevalence and bias adjusted
kappa
Alveolar inﬁltrates 0.421 0.005 0.720 Substantial
Lymphadenopathy 0.285 0.060 0.348 Fair
Cavitation 0.480 <0.0001 0.510 Moderate
Pleural effusion 0.448 0.002 0.636 Substantial
Agreement for continuous variables rc P value 95% limits of agreement (Bland and Altman)
Affected lung area 0.734 <0.0001 -50 to 31.4%
doi:10.1371/journal.pone.0138070.t004
Table 5. Univariable linear regression: association of affected lung area with BMI
Predictor β S.E P value 95%CI for β
Model 1Alveolar inﬁltrates - 0.620 0.229 0.008 -1.073–-0.167
Model 2Affected lung area - 0.034 0.009 <0.0001 -0.052–-0.016
Model 3Alveolar inﬁltrates 0.044 0.359 0.903 -0.666–0.753
Affected lung area - 0.035 0.015 0.019 -0.065–-0.006
Model parameters dependent variable BMI: Model 1 Constant 17.53 ANOVA 0.008, R2 0.044. Model 2 Constant 18.22 ANOVA <0.0001, R2 0.087.
Model 3 Constant 18.21 ANOVA 0.002, R2 0.076.
doi:10.1371/journal.pone.0138070.t005
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category would have more bacteria in the sputum than those in the category below. In the uni-
variable analysis, we found that the extent of alveolar infiltrates, the presence of cavities, and
the affected lung area were associated with the extent of sputum smear positivity (Table 6,
model 1, 2 and 3, respectively). However, the multivariable analysis revealed that only the
extent of alveolar infiltrates and the presence of cavities were independent predictors of sputum
smear positivity (Table 6, model 4).
We performed a further multivariable analysis including only the extent of alveolar infil-
trates and the presence of cavities. This new multivariable model showed that patients with
alveolar infiltrates in two quadrants of the lungs had a higher probability of having the value 3
+ in their sputum smear compared to those with no infiltration (Odds Ratio (OR) 4.33, 95%CI
1.04–19.99) (p 0.044) (Table 6, model 5). The results were similar for patients with alveolar
infiltrates in three and four quadrants of the lungs, (OR 10.84, 95%CI 2.20–53.84) (p 0.003)
and (OR 12.84, 95%CI 2.02–81.77) (p 0.007), respectively (Table 6 model 5). The association in
patients with alveolar infiltrates in only the first quadrant did not reach statistical significance
(OR 3.84, 95%CI 0.90–16.44) (p 0.070). However, the results of the other categories suggest a
trend towards having 3+ in the sputum smear being more likely with an increasing number of
quadrants with alveolar infiltrates. Similarly, patients with no cavities in the lungs were less
likely to have the value 3+ in their sputum smear compared to those with two cavities (OR
0.18, 95%CI 0.03–0.98), (p 0.047), while the difference between patients with one cavity and
two cavities did not reach statistical significance (Table 6, model 5). These results indicate that
the extent of alveolar infiltrates and the presence of cavities are associated with the grade of
sputum smear positivity.
There are differences in drinking habits depending on the extent of
alveolar infiltrates and presence of cavitation
We stratified the study population by the extent of alveolar infiltrates and cavitation, in order
to illustrate how drinking and smoking habits, which have been associated with an increased
risk for PTB, and other clinical and CXR features are distributed according to these two mani-
festations of pulmonary involvement. This analysis revealed that patients with alveolar infil-
trates in all four lung quadrants on CXR reported a higher frequency of drinking habits 60% (p
0.018). Moreover, patients with two lung cavities also reported a higher frequency of drinking
habits 57.1%, (p 0.009) S1 Table, however, the difference in smoking habits according to levels
of infiltration and cavitation did not reach statistical significance S1 Table. These results sug-
gest that there are differences in drinking but not smoking habits related to the extent of alveo-
lar infiltrates and the presence of cavities.
The proportion of affected lung area and cavitation do not predict neither
two-month sputum smear status nor treatment outcome
A scoring system for grading CXR severity in adults with smear-positive PTB based on the pro-
portion of total lung area affected plus 40, if cavitation was present, for predicting the two-
month sputum smear status was recently reported [22]. We assessed whether the proportion of
affected lung area and cavitation, as defined and assessed in our reading scheme, are predictors
of two-month sputum smear status. We performed regression analysis to assess the association
of the proportion of affected lung area and cavitation with two-month sputum smear status in
two separate univariable models and, subsequently, the association with two-month sputum
smear status when the two variables were combined into a score, as recently suggested [22].
However, in our study population and using our CXR reading scheme, neither cavitation nor
the affected lung area separately, or combined into a score, were associated with two-month
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sputum smear results (OR 0.48, 95%CI -0.046–-0.004) (p 0.30), (OR 1.00, 95%CI 0.978–1.036),
(p 0.63) and (OR 1.01, 95%CI 0.994–1.037), (p 0.16), (Table 7 models 1, 2 and 3 respectively).
Next, we evaluated whether there are differences in the proportion of affected lung area and
cavitation between patients that were cured and those who were not cured after six months
DOTS treatment, this analysis did not reveal any significant differences S2 Table.
Changes in the extent of CXRmanifestations after 6 months of DOTS
treatment
In our study, the microbiological cure rate after completion of the treatment was 95%, although
6.4% of patients still had a positive sputum smear after two months of treatment Table 1. To
assess whether the specific CXR manifestations showed differential improvements after
Table 6. Univariable andmultivariable ordinal regression: association of alveolar infiltrates and cavities with number of bacteria in sputum smear.
Predictor β S.E P value Exp β (OR) 95%CI for Exp β (OR)
Model 1Alveolar inﬁltrates
1 quadrant 1.395 0.736 0.058 4.04 0.95–17.06
2 quadrants 1.573 0.719 0.029 4.82 1.82–19.76
3 quadrants 2.436 0.803 0.002 11.43 2.37–55.21
4 quadrants 2.659 0.923 0.004 14.29 2.34–87.21
Model 2Cavitation
No cavities -1.760 0.845 0.037 0.17 0.03–0.90
1 cavity -1.471 0.881 0.095 0.23 0.04–1.29
Model 3Affected lung area 0.016 0.007 0.019 1.02 1.00–1.03
Model 4
Alveolar inﬁltrates
1 quadrant 1.345 0.743 0.070 3.84 0.90–16.45
2 quadrants 1.465 0.772 0.058 4.33 0.95–19.63
3 quadrants 2.382 0.952 0.012 10.83 1.68–70.01
4 quadrants 2.552 1.221 0.037 12.83 1.17–140.5
Cavitation
No cavities -1.727 0.874 0.048 0.18 0.03–0.99
1 cavity -1.605 0.914 0.079 0.20 0.03–1.21
Affected lung area 0.001 0.012 0.997 1.00 0.98–1.02
Model 5
Alveolar inﬁltrates
1 quadrant 1.345 0.742 0.070 3.84 0.90–16.44
2 quadrants 1.465 0.727 0.044 4.33 1.04–19.99
3 quadrants 2.383 0.813 0.003 10.84 2.20–53.84
4 quadrants 2.553 0.945 0.007 12.84 2.02–81.77
Cavitation
No cavities -1.727 0.871 0.047 0.18 0.03–0.98
1 cavity -1.605 0.907 0.077 0.20 0.03–1.19
Dependent ordinal variable sputum smear (<1+, 1+, 2+ and 3+). Model 1 -2Log 52, Chi2 0.015, Goodness of ﬁt 0.88, Pseudo R2 (Cox and snell 0.084
and Nagelkerke 0.091), test of parallel lines 0.021. Model 2 -2Log 27.5, Chi2 0.068, Goodness of ﬁt 0.98, Pseudo R2 (Cox and snell 0.037 and
Nagelkerke 0.040), test of parallel lines 0.971. Model 3 -2Log 53, Chi2 0,020, Goodness of ﬁt 0,083, Pseudo R2 (Cox and snell 0,067 and Nagelkerke
0,041), test of parallel lines 0,240. Model 4 -2Log 158, Chi2 0.08, Goodness of ﬁt 0,012, Pseudo R2 (Cox and snell 0.11 and Nagelkerke 0.12), test of
parallel lines 0.022. Model 5 -2Log 100, Chi2 0.009, Goodness of ﬁt 0,080, Pseudo R2 (Cox and snell 0.11 and Nagelkerke 0.12), test of parallel lines
0.075. Reference categories: Sputum smear: 3+, Alveolar inﬁltrates: No inﬁltration, Cavities: 2 cavities.
doi:10.1371/journal.pone.0138070.t006
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treatment, we performed a repeated measures analysis in 62 patients who also had CXR after
completion of DOTS treatment. As illustrated in Table 8, after 6 months of DOTS treatment
the extent of affected lung area decreased from 56.0% +/- 21.5% to 31.0% +/- 20%. A decrease
was also observed in the extent of alveolar infiltrates in at least one quadrant from 98.4% to
25.8%, presence of cavities from 34.8% to 1.6%, lymphadenopathy from 46.8% to 16.1%, and
pleural effusion from 19.4% to 6.5%. These data suggest that after 6 months of treatment and
despite a significant overall improvement in CXR pulmonary involvement, PTB patients still
showed radiographic abnormalities in their lungs. Subsequently, to assess whether the severity
of lung involvement was associated with less BMI gain after 6 months of DOTS treatment, we
compared the BMI gain between patients according to their affected lung area. This analysis
revealed no difference in BMI gain dependent on affected lung area S3 Fig
Discussion
In this study, our aim was to grade the severity of pulmonary involvement of PTB with a new
reading scheme based on the assessment of the presence and extent of different radiographic
manifestations associated with PTB [22, 27]. The extent of lung involvement and the extent of
alveolar infiltrates were graded by making use of a four quadrant scheme. The presence of cavi-
ties, lymphadenopathy and pleural effusion were included as either present or not present. By
applying this radiographic reading scheme, we found that, in our PTB patients, an average lung
area of 51.7% +/- 23.3% was affected by radiographic abnormalities at diagnosis. In addition,
Table 7. Univariable logistic regression: association of CXR score based on the affected area of the lung and presence of cavitation with two-
month sputum smear.
Predictor β S.E P value Exp β (OR) 95%CI for Exp β
Model 1Cavitation - 0.720 0.698 0.303 0.487 -0.046–-0.004
Model 2Affected lung area 0.007 0.015 0.637 1.007 0.978–1.036
Model 3CXR score: affected lung area plus 40 if cavitation present 0.015 0.011 0.167 1.015 0.994–1.037
Model parameters: Model 1 constant:- 2.22, -2Log likelihood 65.9-Chi2 0.31, Hosmer and lemeshow test <0.0001, R2 (Cox 0.007 and Nagelkerke 0.019).
Model 2 constant:- 3.07, -2Log likelihood 66.7-Chi2 6.37, Hosmer and lemeshow test 0.206, R2 (Cox 0.002 and Nagelkerke 0.004). Model 3 constant:-
3.77, -2Log likelihood 65-Chi2 1.67, Hosmer and lemeshow test 0.446, R2 (Cox 0.013 and Nagelkerke 0.036).
doi:10.1371/journal.pone.0138070.t007
Table 8. Changes in CXR specific features at diagnosis and after 6 months of DOTS therapy.
Variable At diagnosisn = 62 6 months therapyn = 62 P value
Alveolar inﬁltrates n (%)
No 2 (3.2) 46 (74.4)
1 quadrant 16 (25.8) 13 (21)
2 quadrants 32 (51.6) 2 (3.2) <0.0001
3 quadrants 7 (11.3) 1 (1.6)
4 quadrants 5 (8.1)
Lymphadenopathy n (%), (yes/No) 29 (46.8)/33 (53.2) 10 (16.1)/52 (83.9) <0.0001
Cavitation n (%)
No 46 (74.2) 61 (98.4)
1 Cavity 15 (24.8) 1 (1.6) 0.002
2 Cavities 1 (1.6)
Affected lung area mean (SD) 56 ± 21.5 31 ± 20 <0.0001
Pleural effusion n (%), (yes/No) 12 (19.4)/50 (80.6) 4 (6.5)/58 (93.5) 0.008
doi:10.1371/journal.pone.0138070.t008
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94% of the patients had alveolar infiltrates at least in one quadrant and, in 89.4% of the cases,
infiltration could be observed in the upper quadrants, suggesting that most of these patients
had post primary PTB. This is in agreement with other studies which reported that post pri-
mary TB occurs in immunocompetent adults and accounts for about 80% of all clinical cases
and nearly 100% of infection transmission [29, 38]. In our study, cavitation was found in 29.1%
of the patients, which is in agreement with the prevalence reported by other studies in PTB
patients [39]. Interestingly, good inter-reader reliability could be found for grading the affected
lung area, as well as for grading the extent of alveolar infiltrates, suggesting that our simple
reading scheme has the potential for accurate and reproducible CXR grading of disease severity
of PTB. For the detection of cavities, inter-reader reliability was surprisingly moderate. There-
fore, cavitation can be a very distinct feature of PTB that is easy to detect, but in other settings,
it can be overlooked [18, 39].
To substantiate our finding that different CXR manifestations correlate with BMI and spu-
tum smear positivity as adequate well-known parameters of disease severity at diagnosis, we
found that the extent of lung involvement was related to BMI, whereas the extent of alveolar
infiltrates, along with the presence of cavitation, was strongly associated with sputum smear
positivity. Our findings are in agreement with those that found a similar correlation between
BMI and radiographic features of lung involvement [20]. By assessing the extent of alveolar
infiltrates with the new reading scheme, we found that this feature was associated with sputum
smear positivity. In the early inflammatory state of acute post primary PTB, the extent of local
pulmonary disease pathology, and in particular of tuberculous pneumonia, has been shown to
be associated with the bacillary load in the sputum of TB patients [28, 32, 40]. Therefore, our
findings support the observation that the extent of alveolar infiltrates assessed with the new
reading scheme reflects this early state in PTB and its relation to increased infectivity. As
expected, we also found an association between sputum smear positivity and the presence of
cavities, which is in agreement with the findings of several other studies [25, 41, 42]. The pres-
ence of lymphadenopathy and pleural effusion, albeit with a fair level of agreement, was neither
associated with BMI nor with sputum smear positivity. Consequently, these CXR features most
likely reflect the local disease status.
Our results suggest that the use of individual CXR manifestations might be more appropri-
ate and practical in assessing disease severity than the use of a score system. Although the
extent of alveolar infiltrates and cavitation are both predictors of sputum smear positivity, alve-
olar infiltration has a higher level of agreement between radiologists and, therefore, it might be
a more reliable proxy marker of infectivity. It is also probable that each CXR manifestation
reflects different pathophysiological stages of the disease. We judged the association of the pro-
portion of affected lung area and cavitation as evaluated in our reading scheme with two-
month sputum smear status as recently suggested [22], but we did not find an association
between the extents of affected lung area or cavitation and two-month sputum smear status.
However, the methodology that we used to assess lung involvement was not entirely compara-
ble to the one previously used [22], which might be the reason for the discrepancies between
the two studies. A recent meta-analysis revealed that sputum smear examination at the end of
the second month of treatment has only low sensitivity and modest specificity for predicting
treatment failure and relapse, therefore it might not greatly add to scoring systems for predict-
ing the outcome of PTB [43].
The microbiological cure rate in our study after 6 months of DOTS treatment was 95%,
although 4% of patients still had positive sputum smear after two months of treatment.
Accordingly, CXR findings of all patients improved after 6 months of treatment. But, approxi-
mately one third of the patients still showed PTB associated radiographic abnormalities in at
least one quadrant. Noteworthy, it was recently shown that in patients with cured PTB, the
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degree of radiographic abnormalities evaluated using a scoring system comparable to the one
used in our study, was significantly and inversely associated with spirometric impairment
assessed by FVC and FEV1 [27]. These findings have recently been confirmed by another
study demonstrating that 34.3% of patients with a history of PTB had non-reversible chronic
airway obstruction that was associated with significantly more radiographic abnormalities in
CXRs [44]. It is therefore likely that, despite the microscopically cure rate of 95%, the existing
pulmonary lesions in the CXRs of our patients might at least partly reflect persistent respira-
tory impairments. Since CXR is often not available for the diagnosis and follow up of PTB
patients in low income settings, there are only few data comparing the radiographic pulmonary
involvement at diagnosis and after 6 months of DOTS treatment. A recent study reported that
after 6 months of DOTS treatment, 27% of TB patients still had at least moderate-severe pul-
monary function impairment, and 57% still had respiratory symptoms, despite most achieving
'successful' treatment outcomes [45]. These findings support an association of the area of lung
affected with severity of pulmonary involvement. The extent of alveolar infiltrates as a different
and more distinct manifestation of our reading scheme decreased from 98.4% to 25.8% of
patients with infiltrates in at least one quadrant. It is likely that a considerable proportion of
the patients analyzed in a previous study in which a reduced FEV1 could be related to the area
of lung affected, was due to the presence of persistent alveolar infiltrates [27]. However, in fol-
low-up studies, this manifestation was not independently investigated in terms of its associa-
tion with PTB pathology and its impact on long-term outcome so far.
One additional finding of our study was that, after 6 months of treatment, the presence of
cavities decreased substantially from 34,8% to 1.6%, which was an excellent cure rate compared
to another study which found that from 53.1% of the PTB patients who presented cavities in
CXR at diagnosis, 16.9% of subjects still had persistent cavities at the end of 6 months of treat-
ment, that was associated with an increased risk of TB relapse [46]. Further studies are needed
in order to investigate which factors are associated with the reduction in the presence of cavities
observed in our study. In our cohort, we also found that lymphadenopathy decreased from
46.8% to 16.1% and pleural effusion from 19.4% to 6.5% after 6 months of treatment. No data
are available that associate lymphadenopathy independently with long-term outcome or short-
and long-term pulmonary function impairment. But, in one study, persistent pleural effusion
in PTB was shown to be associated with pleural thickening and a slowed FEV1 and FVC
increase after 6 months treatment [47].
Taken together, we found that most of the radiological manifestations we investigated were
differentially associated with parameters of disease severity and each changed to a different
extent after 6 months treatment. Since, according to the RNTCP, the standard DOTS treatment
regime for all PTB patients was based on a three times per week application, it is tempting to
speculate that patients with severe disease, according to different manifestations, might benefit
from an intensification of the frequency of antibiotic therapy. One of the limitations of our
study was the absence of other clinical parameters correlated with disease severity, such as
underlying lung disease, as well as FEV1, which would have allowed the assessment of its asso-
ciation with individual CXR manifestations and their confounding effect on the association
between the extent of CXR features with BMI and sputum smear grade. In addition, only 62
patients could be followed by CXR from diagnosis to the completion of DOTS treatment and,
since we only studied CXRs from HIV-negative smear positive patients, our findings need to
be evaluated further for HIV-positive and/ or smear-negative patients with PTB.
In conclusion, we have developed a new assessment scheme to grade the presence and extent
of specific CXR features and pulmonary disease severity in patients with PTB. By differentially
analyzing the five radiographic manifestations, i.e., lung involvement, alveolar infiltration, cavi-
tation, lymphadenopathy and pleural effusion our grading scheme factors the broad
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heterogeneity in pulmonary pathology allowing the integration of differential information
regarding disease severity into clinical decision-making. Prospective studies are required to eval-
uate this reading scheme in representative populations, and to determine the association of each
manifestation with short- and long-term pulmonary function impairment and whether there
would be any benefit to lengthening or modulating therapy based on CXR severity assessment.
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